封面
市場調查報告書
商品編碼
1125957

持續血糖監測系統 (CGM) 的全球市場 (2022年-2027年):市場規模、預測、產業趨勢、佔有率、成長率、見解、COVID-19影響、企業分析

Continuous Glucose Monitoring (CGM) Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Countries, Company Analysis

出版日期: | 出版商: Renub Research | 英文 300 Pages | 商品交期: 最快1-2個工作天內

價格

全球持續血糖監測系統 (CGM) 的市場規模從2021年到2027年預計以6.60%年複合成長率發展,2027年成長到84億8,000萬美元的規模。

老年人口的劇增,及糖尿病的盛行率增加成為擴大該市場的重要要素。隨著糖尿病患者增加,許多進入經營者開發創新的產品和產品線,預計促進市場成長。

本報告提供全球持續血糖監測系統 (CGM) 的市場調查,市場概要,市場成長的影響因素的分析,市場規模 (金額、數量) 的變化、預測,各主要國家的詳細分析,主要企業簡介等彙整資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 促進因素
  • 課題

第5章 全球持續血糖監測系統 (CGM) 市場、用戶分析

  • 市場
  • 用戶

第6章 全球持續血糖監測系統 (CGM) 市場:各零件

  • 血糖感測器市場
  • CGM傳送器市場

第7章 全球持續血糖監測系統 (CGM) 市場、CGM用戶佔有率分析

  • CGM市場佔有率
  • CGM用戶佔有率

第8章 全球CGM (持續血糖監測系統) 償付模式

第9章 Abbott Freestyle Libre和CGM (持續血糖監測系統)

第10章 美國

  • 糖尿病人口
  • 市場規模
  • 用戶數
  • 償付

第11章 加拿大

  • 糖尿病人口
  • 市場規模
  • 用戶數
  • 償付

第12章 德國

  • 糖尿病人口
  • 市場規模
  • 用戶數
  • 償付

第13章 澳洲

  • 糖尿病人口
  • 市場規模
  • 用戶數
  • 償付

第14章 法國

  • 糖尿病人口
  • 市場規模
  • 用戶數
  • 償付

第15章 荷蘭

  • 糖尿病人口
  • 市場規模
  • 用戶數
  • 償付

第16章 瑞士

  • 糖尿病人口
  • 市場規模
  • 用戶數
  • 償付

第17章 瑞典

  • 糖尿病人口
  • 市場規模
  • 用戶數
  • 償付

第18章 以色列

  • 糖尿病人口
  • 市場規模
  • 用戶數
  • 償付

第19章 英國

  • 糖尿病人口
  • 市場規模
  • 用戶數
  • 償付

第20章 日本

第21章 企業分析

  • Abbott Laboratories
  • Roche
  • Tandem Diabetes Care
  • Dexcom Inc
  • Senseonics

According to Renub Research, Continuous Glucose Monitoring Market is estimated to reach US$ 8.48 Billion by 2027. One of the most recent technical evolutions in diabetes management is continuous glucose monitoring (CGM). In brief, a CGM system is a form of glucose monitoring device that works by inserting a biosensor either transcutaneously or subcutaneously. Furthermore, the embedded sensor detects glucose levels in interstitial fluid or blood. It communicates the data to a receiver/monitor for display. Due to their numerous advantages over traditional glucose monitoring devices, these systems play an essential role in diabetes care. Unlike traditional glucose monitors, these devices allow for continuous glucose monitoring, which is critical for avoiding diabetic complications.

Global Continuous Glucose Monitoring Market Size Is Expanding with a CAGR Of 6.60% During 2021-2027:

The spike in the geriatric population and the increasing prevalence of diabetes have been essential factors driving the CGM market's expansion over the years worldwide. Furthermore, as the number of diabetic cases rises, the market for continuous glucose monitoring systems is predicted to grow and expand, attracting and compelling many industry participants to develop innovative products or product line extensions. Moreover, substantial growth potential in undeveloped areas is expected to generate significant profit opportunities for manufacturers during the anticipated period. However, a lack of proper funding for devices is a substantial impediment to their widespread adoption.

COVID-19 Impact on Continuous Glucose Monitoring Industry:

According to the World Health Organization (WHO), the number of people with type 2 diabetes has been rising in most nations, according to the World Health Organization (WHO). Furthermore, according to our findings, the COVID-19 epidemic has increased the necessity of evaluating the feasibility of continuous glucose monitoring (CGM) in hospitals to preserve personal protective equipment (PPE) and restrict exposure to health care workers. As a result, the Continuous Glucose Monitoring Market has grown even during the epidemic. Moreover, as per our analysis, Global Continuous Glucose Monitoring Market reached US$. 5.78 Billion in 2021.

Segment Analysis in Continuous Glucose Monitoring Market:

The Global Continuous Glucose Monitoring Market is studied in the United States, Canada, Germany, Australia, France, Netherlands, Switzerland, Sweden, Israel, United Kingdom, and Japan. Further, the market in detail is categorized based on Diabetes Population (Type 1 and Type 2, CGM Market, CGM Market by Components, Glucose Sensor Market, CGM Transmitter Market, CGM User, and CGM Reimbursement.

Competitive Landscape:

The Continuous Glucose Monitoring (CGM) Market is highly competitive, with only a few companies competing. Abbott Laboratories, Roche, Tandem Diabetes Care, Dexcom Inc, and Senseonics are among the important players profiled in our analysis. These firms control a significant portion of the global market. In addition, they are continually entering new markets to develop new revenue streams and strengthen existing ones. These market actors' actions will create a competitive marketplace, forcing enterprises to experiment with the latest technology to maintain originality in their products. Companies are also working together to improve their technical knowledge and shorten the product development cycle.

Renub Research latest report "Continuous Glucose Monitoring (CGM) Market, Global Forecast, By Components (Glucose Sensor Market and CGM Transmitter Market), Countries (United States, Canada, Germany, Australia, France, Netherlands, Switzerland, Sweden, Israel, United Kingdom and Japan), Country Insights (Diabetes Population (Type 1 and Type 2), CGM Market, CGM Market by Components, Glucose Sensor Market, CGM Transmitter Market, CGM User and CGM Reimbursement), Companies (Abbott Laboratories, Roche, Tandem Diabetes Care, Dexcom Inc, and Senseonics)" provides a detailed analysis of Continuous Glucose Monitoring (CGM) Industry.

By Components - the market has been studied based on 2 viewpoints:

1. Glucose Sensor Market

2. CGM Transmitter Market

By Countries - the market has been studied for 11 countries:

1. United States

2. Canada

3. Germany

4. Australia

5. France

6. Netherlands

7. Switzerland

8. Sweden

9. Israel

10. United Kingdom

11. Japan

The above-mentioned countries have been studied from 7 viewpoints:

1. Diabetes Population

  • Type 1
  • Type 2

2. CGM Market

3. CGM Market by Components

4. Glucose Sensor Market

5. CGM Transmitter Market

6. CGM User

7. CGM Reimbursement

Company Insights:

  • Overview
  • Recent Development
  • Revenue

Companies Covered:

1. Abbott Laboratories

2. Roche

3. Tandem Diabetes Care

4. Dexcom Inc

5. Senseonics

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Global CGM Market and User Analysis

  • 5.1 Market
  • 5.2 User

6. By Components - Continuous Glucose Monitoring Market

  • 6.1 Glucose Sensor Market
  • 6.2 CGM Transmitter Market

7. Global CGM Market and CGM User Share Analysis

  • 7.1 CGM Market Share
    • 7.1.1 Glucose Sensor Market Share
    • 7.1.2 CGM Transmitter Market Share
  • 7.2 CGM User Share

8. Global CGM (Continuous Glucose Monitoring) Reimbursement Model

9. Abbott Freestyle Libre vs CGM (Continuous Glucose Monitoring)

10. United States

  • 10.1 Diabetes Population
    • 10.1.1 Type 1
    • 10.1.2 Type 2
  • 10.2 United States - CGM Market
    • 10.2.1 United States - CGM Market by Components
      • 10.2.1.1 Glucose Sensor Market
      • 10.2.1.2 CGM Transmitter Market
  • 10.3 United States - CGM User
  • 10.4 CGM Reimbursement in United States

11. Canada

  • 11.1 Diabetes Population
    • 11.1.1 Type 1
    • 11.1.2 Type 2
  • 11.2 Canada - CGM Market
    • 11.2.1 Canada - CGM Market by Components
      • 11.2.1.1 Glucose Sensor Market
      • 11.2.1.2 CGM Transmitter Market
  • 11.3 Canada - CGM User
  • 11.4 CGM Reimbursement in United States

12. Germany

  • 12.1 Diabetes Population
    • 12.1.1 Type 1
    • 12.1.2 Type 2
  • 12.2 Germany - CGM Market
    • 12.2.1 Germany - CGM Market by Components
      • 12.2.1.1 Glucose Sensor Market
      • 12.2.1.2 CGM Transmitter Market
  • 12.3 Germany - CGM User
  • 12.4 CGM Reimbursement in United States

13. Australia

  • 13.1 Diabetes Population
    • 13.1.1 Type 1
    • 13.1.2 Type 2
  • 13.2 Australia - CGM Market
    • 13.2.1 Australia - CGM Market by Components
      • 13.2.1.1 Glucose Sensor Market
      • 13.2.1.2 CGM Transmitter Market
  • 13.3 Australia - CGM User
  • 13.4 CGM Reimbursement in United States

14. France

  • 14.1 Diabetes Population
    • 14.1.1 Type 1
    • 14.1.2 Type 2
  • 14.2 France - CGM Market
    • 14.2.1 France - CGM Market by Components
      • 14.2.1.1 Glucose Sensor Market
      • 14.2.1.2 CGM Transmitter Market
  • 14.3 France - CGM User
  • 14.4 CGM Reimbursement in United States

15. Netherlands

  • 15.1 Diabetes Population
    • 15.1.1 Type 1
    • 15.1.2 Type 2
  • 15.2 Netherlands - CGM Market
    • 15.2.1 Netherlands - CGM Market by Components
      • 15.2.1.1 Glucose Sensor Market
      • 15.2.1.2 CGM Transmitter Market
  • 15.3 Netherlands - CGM User
  • 15.4 CGM Reimbursement in United States

16. Switzerland

  • 16.1 Diabetes Population
    • 16.1.1 Type 1
    • 16.1.2 Type 2
  • 16.2 Switzerland - CGM Market
    • 16.2.1 Switzerland - CGM Market by Components
      • 16.2.1.1 Glucose Sensor Market
      • 16.2.1.2 CGM Transmitter Market
  • 16.3 Switzerland - CGM User
  • 16.4 CGM Reimbursement in United States

17. Sweden

  • 17.1 Diabetes Population
    • 17.1.1 Type 1
    • 17.1.2 Type 2
  • 17.2 Sweden - CGM Market
    • 17.2.1 Sweden - CGM Market by Components
      • 17.2.1.1 Glucose Sensor Market
      • 17.2.1.2 CGM Transmitter Market
  • 17.3 Sweden - CGM User
  • 17.4 CGM Reimbursement in United States

18. Israel

  • 18.1 Diabetes Population
    • 18.1.1 Type 1
    • 18.1.2 Type 2
  • 18.2 Israel - CGM Market
    • 18.2.1 Israel - CGM Market by Components
      • 18.2.1.1 Glucose Sensor Market
      • 18.2.1.2 CGM Transmitter Market
  • 18.3 Israel - CGM User
  • 18.4 CGM Reimbursement in United States

19. United Kingdom

  • 19.1 Diabetes Population
    • 19.1.1 Type 1
    • 19.1.2 Type 2
  • 19.2 United Kingdom - CGM Market
    • 19.2.1 United Kingdom - CGM Market by Components
      • 19.2.1.1 Glucose Sensor Market
      • 19.2.1.2 CGM Transmitter Market
  • 19.3 United Kingdom - CGM User
  • 19.4 CGM Reimbursement in United States

20. Japan

  • 20.1 Diabetes Population
    • 20.1.1 Type 1
    • 20.1.2 Type 2
  • 20.2 Japan - CGM Market
    • 20.2.1 Japan - CGM Market by Components
      • 20.2.1.1 Glucose Sensor Market
      • 20.2.1.2 CGM Transmitter Market
  • 20.3 Japan - CGM User
  • 20.4 CGM Reimbursement in United States

21 Company Analysis

  • 21.1 Abbott Laboratories
    • 21.1.1 Overview
    • 21.1.2 Recent Development
    • 21.1.3 Revenue
  • 21.2 Roche
    • 21.2.1 Overview
    • 21.2.2 Recent Development
    • 21.2.3 Revenue
  • 21.3 Tandem Diabetes Care
    • 21.3.1 Overview
    • 21.3.2 Recent Development
    • 21.3.3 Revenue
  • 21.4 Dexcom Inc
    • 21.4.1 Overview
    • 21.4.2 Recent Development
    • 21.4.3 Revenue
  • 21.5 Senseonics
    • 21.5.1 Overview
    • 21.5.2 Recent Development
    • 21.5.3 Revenue

List of Figures

  • Figure-01: Global - Continuous Glucose Monitoring Market (Million US$), 2017 - 2021
  • Figure-02: Global - Forecast for Continuous Glucose Monitoring Market (Million US$), 2022 - 2027
  • Figure-03: Global - Continuous Glucose Monitoring User Volume (Thousand), 2017 - 2021
  • Figure-04: Global - Forecast for Continuous Glucose Monitoring User Volume (Thousand), 2022 - 2027
  • Figure-05: Global - Glucose Sensor Market (Million US$), 2017 - 2021
  • Figure-06: Global - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
  • Figure-07: Global - CGM Transmitter Market (Million US$), 2017 - 2021
  • Figure-08: Global - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
  • Figure-09: United States - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
  • Figure-10: United States - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
  • Figure-11: United States - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
  • Figure-12: United States - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
  • Figure-13: United States - Glucose Sensor Market (Million US$), 2017 - 2021
  • Figure-14: United States - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
  • Figure-15: United States - CGM Transmitter Market (Million US$), 2017 - 2021
  • Figure-16: United States - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
  • Figure-17: United States - CGM User Volume (Number), 2017 - 2021
  • Figure-18: United States - Forecast for CGM User Volume (Number), 2022 - 2027
  • Figure-19: Canada - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
  • Figure-20: Canada - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
  • Figure-21: Canada - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
  • Figure-22: Canada - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
  • Figure-23: Canada - Glucose Sensor Market (Million US$), 2017 - 2021
  • Figure-24: Canada - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
  • Figure-25: Canada - CGM Transmitter Market (Million US$), 2017 - 2021
  • Figure-26: Canada - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
  • Figure-27: Canada - CGM User Volume (Number), 2017 - 2021
  • Figure-28: Canada - Forecast for CGM User Volume (Number), 2022 - 2027
  • Figure-29: Germany - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
  • Figure-30: Germany - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
  • Figure-31: Germany - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
  • Figure-32: Germany - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
  • Figure-33: Germany - Glucose Sensor Market (Million US$), 2017 - 2021
  • Figure-34: Germany - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
  • Figure-35: Germany - CGM Transmitter Market (Million US$), 2017 - 2021
  • Figure-36: Germany - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
  • Figure-37: Germany - CGM User Volume (Number), 2017 - 2021
  • Figure-38: Germany - Forecast for CGM User Volume (Number), 2022 - 2027
  • Figure-39: Australia - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
  • Figure-40: Australia - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
  • Figure-41: Australia - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
  • Figure-42: Australia - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
  • Figure-43: Australia - Glucose Sensor Market (Million US$), 2017 - 2021
  • Figure-44: Australia - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
  • Figure-45: Australia - CGM Transmitter Market (Million US$), 2017 - 2021
  • Figure-46: Australia - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
  • Figure-47: Australia - CGM User Volume (Number), 2017 - 2021
  • Figure-48: Australia - Forecast for CGM User Volume (Number), 2022 - 2027
  • Figure-49: France - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
  • Figure-50: France - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
  • Figure-51: France - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
  • Figure-52: France - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
  • Figure-53: France - Glucose Sensor Market (Million US$), 2017 - 2021
  • Figure-54: France - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
  • Figure-55: France - CGM Transmitter Market (Million US$), 2017 - 2021
  • Figure-57: France - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
  • Figure-56: France - CGM User Volume (Number), 2017 - 2021
  • Figure-58: France - Forecast for CGM User Volume (Number), 2022 - 2027
  • Figure-59: Netherlands - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
  • Figure-60: Netherlands - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
  • Figure-61: Netherlands - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
  • Figure-62: Netherlands - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
  • Figure-63: Netherlands - Glucose Sensor Market (Million US$), 2017 - 2021
  • Figure-64: Netherlands - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
  • Figure-65: Netherlands - CGM Transmitter Market (Million US$), 2017 - 2021
  • Figure-66: Netherlands - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
  • Figure-67: Netherlands - CGM User Volume (Number), 2017 - 2021
  • Figure-68: Netherlands - Forecast for CGM User Volume (Number), 2022 - 2027
  • Figure-69: Switzerland - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
  • Figure-70: Switzerland - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
  • Figure-71: Switzerland - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
  • Figure-72: Switzerland - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
  • Figure-73: Switzerland - Glucose Sensor Market (Million US$), 2017 - 2021
  • Figure-74: Switzerland - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
  • Figure-75: Switzerland - CGM Transmitter Market (Million US$), 2017 - 2021
  • Figure-76: Switzerland - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
  • Figure-77: Switzerland - CGM User Volume (Number), 2017 - 2021
  • Figure-78: Switzerland - Forecast for CGM User Volume (Number), 2022 - 2027
  • Figure-79: Sweden - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
  • Figure-80: Sweden - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
  • Figure-81: Sweden - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
  • Figure-82: Sweden - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
  • Figure-83: Sweden - Glucose Sensor Market (Million US$), 2017 - 2021
  • Figure-84: Sweden - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
  • Figure-85: Sweden - CGM Transmitter Market (Million US$), 2017 - 2021
  • Figure-86: Sweden - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
  • Figure-87: Sweden - CGM User Volume (Number), 2017 - 2021
  • Figure-88: Sweden - Forecast for CGM User Volume (Number), 2022 - 2027
  • Figure-89: Israel - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
  • Figure-90: Israel - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
  • Figure-91: Israel - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
  • Figure-92: Israel - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
  • Figure-93: Israel - Glucose Sensor Market (Million US$), 2017 - 2021
  • Figure-94: Israel - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
  • Figure-95: Israel - CGM Transmitter Market (Million US$), 2017 - 2021
  • Figure-96: Israel - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
  • Figure-97: Israel - CGM User Volume (Number), 2017 - 2021
  • Figure-98: Israel - Forecast for CGM User Volume (Number), 2022 - 2027
  • Figure-99: United Kingdom - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
  • Figure-100: United Kingdom - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
  • Figure-101: United Kingdom - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
  • Figure-102: United Kingdom - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
  • Figure-103: United Kingdom - Glucose Sensor Market (Million US$), 2017 - 2021
  • Figure-104: United Kingdom - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
  • Figure-105: United Kingdom - CGM Transmitter Market (Million US$), 2017 - 2021
  • Figure-106: United Kingdom - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
  • Figure-107: United Kingdom - CGM User Volume (Number), 2017 - 2021
  • Figure-108: United Kingdom - Forecast for CGM User Volume (Number), 2022 - 2027
  • Figure-109: Japan - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
  • Figure-110: Japan - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
  • Figure-111: Japan - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
  • Figure-112: Japan - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
  • Figure-113: Japan - Glucose Sensor Market (Million US$), 2017 - 2021
  • Figure-114: Japan - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
  • Figure-115: Japan - CGM Transmitter Market (Million US$), 2017 - 2021
  • Figure-116: Japan - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
  • Figure-117: Japan - CGM User Volume (Number), 2017 - 2021
  • Figure-118: Japan - Forecast for CGM User Volume (Number), 2022 - 2027
  • Figure-119: Abbott Laboratories - Global Revenue (Million US$), 2017 - 2021
  • Figure-120: Abbott Laboratories - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-121: Roche - Global Revenue (Million US$), 2017 - 2021
  • Figure-122: Roche - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-123: Tandem Diabetes Care - Global Revenue (Million US$), 2017 - 2021
  • Figure-124: Tandem Diabetes Care - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-125: Dexcom Inc - Global Revenue (Million US$), 2017 - 2021
  • Figure-126: Dexcom Inc - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-127: Senseonics - Global Revenue (Million US$), 2017 - 2021
  • Figure-128: Senseonics - Forecast for Global Revenue (Million US$), 2022 - 2027

List of Tables

  • Table-01: Global - CGM Market Share by Countries (Percent), 2017 - 2021
  • Table-02: Global - Forecast for CGM Market Share by Countries (Percent), 2022 - 2027
  • Table-03: Global - Glucose Sensor Market Share by Countries (Percent), 2017 - 2021
  • Table-04: Global - Forecast for Glucose Sensor Market Share by Countries (Percent), 2022 - 2027
  • Table-05: Global - CGM Transmitter Market Share by Countries (Percent), 2017 - 2021
  • Table-06: Global - Forecast for CGM Transmitter Market Share by Countries (Percent), 2022 - 2027
  • Table-07: Global - CGM User Volume Share by Countries (Percent), 2017 - 2021
  • Table-08: Global - Forecast for CGM User Volume Share by Countries (Percent), 2022 - 2027